Biologics and Benefit Design: What’s New For ’06?

摘要

With an anticipated spate of new products still on the horizon and the need to focus now on Medicare’s new drug benefit, health plans and employers are more likely to tweak than overhaul biologics coverage in 2006. Key trends include higher cost sharing with employees and a continued effort to move biotech drugs from the medical to the pharmacy benefit.